Conformis Continues Business Model Transition

Conformis reported 1Q22 orthopedic sales of $15.6 million, +12.4% compared to 1Q21.

Revenue from product sales increased +8.9% in the quarter, driven by fewer canceled surgeries, a modest increase in overall procedure volume, and Conformis' expanding ASC channel.

The company is shifting its business model to rely more heavily on...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us